Literature DB >> 21164159

Increasing deaths involving oxycodone, Victoria, Australia, 2000-09.

Angela C Rintoul1, Malcolm D H Dobbin, Olaf H Drummer, Joan Ozanne-Smith.   

Abstract

OBJECTIVE: In light of an emerging epidemic identified in the United States and Canada, to identify trends in fatal drug toxicity involving oxycodone and the demographic characteristics and indicators of socioeconomic disadvantage of the deceased. STUDY
DESIGN: Population-based observational study in Victoria, Australia. POPULATION: Decedents whose death was reported to the Victorian Coroner between 2000 and 2009 and where oxycodone was detected. MAIN OUTCOME MEASURES: Association between supply of oxycodone and deaths. Demographic characteristics of decedents. Rate ratios of the rural or metropolitan location and socioeconomic indicators of disadvantage of the deceased.
RESULTS: Supply to Victoria has increased nine-fold from 7.5 mg per capita in 2000 to 67.5 mg per capita in 2009. Detection of oxycodone in deaths reported to the Victorian Coroner has increased from 4 (0.08/100,000 population) in 2000 to 97 (1.78/100,000 population) in 2009-a 21-fold increase in deaths. Of the 320 cases described, 53.8% (172) were the result of drug toxicity. Of these, 52.3% were unintentional and 19.8% intentional self-harm; the remaining 27.9% are either still under investigation by the coroner or intent is unknown. Drug toxicity deaths were overrepresented in both rural areas and areas indexed with high levels of disadvantage.
CONCLUSIONS: The substantial increase in the number of deaths involving oxycodone is strongly and significantly associated with the increase in supply. Most drug toxicity deaths involving oxycodone were unintentional. This newly identified trend in fatalities in Victoria supports concerns that a pattern of increasing deaths involving oxycodone is emerging globally.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21164159     DOI: 10.1136/ip.2010.029611

Source DB:  PubMed          Journal:  Inj Prev        ISSN: 1353-8047            Impact factor:   2.399


  20 in total

1.  Sensitivity and specificity of administrative mortality data for identifying prescription opioid-related deaths.

Authors:  Emilie Gladstone; Kate Smolina; Steven G Morgan; Kimberly A Fernandes; Diana Martins; Tara Gomes
Journal:  CMAJ       Date:  2015-11-30       Impact factor: 8.262

2.  Trends in methamphetamine and opioid use among clients of needle-syringe programs in Queensland, Australia: 2007-2015.

Authors:  Brendan Jacka; Robert Kemp; Louisa Degenhardt; Amy Peacock; Philip Clare; Raimondo Bruno; Abhilash Dev; Oluwadamisola Sotade; Briony Larance
Journal:  Drug Alcohol Rev       Date:  2019-02-13

3.  Does Prescription Opioid Shopping Increase Overdose Rates in Medicaid Beneficiaries?

Authors:  Benjamin C Sun; Nicoleta Lupulescu-Mann; Christina J Charlesworth; Hyunjee Kim; Daniel M Hartung; Richard A Deyo; K John McConnell
Journal:  Ann Emerg Med       Date:  2017-11-24       Impact factor: 5.721

4.  The Contemporary American Drug Overdose Epidemic in International Perspective.

Authors:  Jessica Y Ho
Journal:  Popul Dev Rev       Date:  2019-02-20

5.  Prescription opioid poisoning across urban and rural areas: identifying vulnerable groups and geographic areas.

Authors:  Magdalena Cerdá; Andrew Gaidus; Katherine M Keyes; William Ponicki; Silvia Martins; Sandro Galea; Paul Gruenewald
Journal:  Addiction       Date:  2016-09-02       Impact factor: 6.526

6.  An update on oxycodone: lessons for death investigators in Australia.

Authors:  Jennifer L Pilgrim; Sabrina Putrianita Yafistham; Sanjeev Gaya; Eva Saar; Olaf H Drummer
Journal:  Forensic Sci Med Pathol       Date:  2014-11-18       Impact factor: 2.007

7.  What analgesics do older people use prior to initiating oxycodone for non-cancer pain? A retrospective database study.

Authors:  Svetla Gadzhanova; J Simon Bell; Elizabeth E Roughead
Journal:  Drugs Aging       Date:  2013-11       Impact factor: 3.923

8.  Increase in opiate prescription in Germany between 2000 and 2010: a study based on insurance data.

Authors:  Ingrid Schubert; Peter Ihle; Rainer Sabatowski
Journal:  Dtsch Arztebl Int       Date:  2013-01-25       Impact factor: 5.594

Review 9.  An overview of the patterns of prescription opioid use, costs and related harms in Australia.

Authors:  Bianca Blanch; Sallie-Anne Pearson; Paul S Haber
Journal:  Br J Clin Pharmacol       Date:  2014-11       Impact factor: 4.335

10.  Prescription opioid use disorder and heroin use among 12-34 year-olds in the United States from 2002 to 2014.

Authors:  Silvia S Martins; Luis E Segura; Julian Santaella-Tenorio; Alexander Perlmutter; Miriam C Fenton; Magdalena Cerdá; Katherine M Keyes; Lilian A Ghandour; Carla L Storr; Deborah S Hasin
Journal:  Addict Behav       Date:  2016-08-30       Impact factor: 3.913

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.